Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000007770 | SCV001217105 | pathogenic | Charcot-Marie-Tooth disease type 2B | 2019-02-18 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with phenylalanine at codon 129 of the RAB7A protein (p.Leu129Phe). The leucine residue is highly conserved and there is a small physicochemical difference between leucine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with Charcot-Marie-Tooth disease in a large family, and is thought to be a founder mutation originating from Austria (PMID: 12545426, 19651702, 10636124, 11094113). ClinVar contains an entry for this variant (Variation ID: 7345). This variant has been reported to affect RAB7A protein function (PMID: 24521780, 23179371, 26791407, 18272684, 21151572, 23188822, 20028791). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000007770 | SCV000027971 | pathogenic | Charcot-Marie-Tooth disease type 2B | 2003-03-01 | no assertion criteria provided | literature only | |
Uni |
RCV000059221 | SCV000090750 | not provided | not provided | no assertion provided | not provided | ||
Inherited Neuropathy Consortium | RCV000789555 | SCV000928911 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |